Multi-peptide stacks.
Reference pages for the multi-peptide cocktails researchers most commonly ask about — how the components work together, typical reconstitution patterns, and citations.
How peptide stacks are usually framed
Almost every peptide stack documented in research-peptide forums is built around the same idea: pair two or more peptides whose mechanisms are thought to be complementary, and run them together for a defined cycle. The healing-peptide pair of BPC-157 and TB-500 — sometimes called the Wolverine stack — pairs a gastric-pentadecapeptide healing factor with a thymosin-beta-4-derived peptide involved in actin remodeling. The growth-hormone-secretagogue pair of CJC-1295 and ipamorelin combines a GHRH analogue with a selective ghrelin-receptor agonist. Each pairing has a different theoretical rationale, and the published evidence for the combination is almost always weaker than for the individual components.
The stack pages on this site catalogue the named cocktails — KLOW, GLOW, Wolverine, GHK-Cu plus BPC-157, CJC-1295 plus ipamorelin, and others — alongside their components, the pharmacological rationale where one is published, and citations. Each component links back to its own peptide page so the calculator math, dose ranges, and source references are one click away. Reconstitution is per-peptide: stacks are not blended into a single vial unless a compounding pharmacy has specifically prepared the formulation.
These pages are not protocols. Choosing whether to combine peptides at all, and at what doses and for how long, is a clinical or research decision that sits entirely outside the scope of this site. The reference math is published so that researchers and laboratory professionals can verify the numbers in published research-only protocol literature.
The Wolverine stack peptides — BPC-157 and TB-500 (Thymosin Beta-4) — are paired for connective-tissue support during recovery. The BPC-157 and TB-500 blend is widely cited in injury-recovery protocols, though human trial data on either peptide remains limited and the stack's name is informal — it does not appear in the peer-reviewed literature.
The KLOW peptide blend (also called the KLOW stack) is a multi-peptide formulation popularised by anti-aging clinics. The composition varies by source — common KLOW peptide members include Kisspeptin-10 (HPG-axis stimulation), CJC-1295 (GHRH analogue), Ipamorelin (GH secretagogue), and Tesamorelin (GHRH analogue). Some KLOW formulations also include GHK-Cu and BPC-157.
GLOW combines GHK-Cu, BPC-157, and TB-500 in a single recovery- and skin-focused blend. It targets connective-tissue repair and dermal endpoints simultaneously and is often delivered as a single multi-peptide vial.
The CJC-1295 + ipamorelin combination is the most widely used growth-hormone-axis stack. CJC-1295 is a GHRH analogue; ipamorelin is a selective GH secretagogue. Co-administration produces a synergistic GH pulse larger than either component alone.
A two-peptide combination combining GHK-Cu's collagen and skin-repair effects with BPC-157's gastrointestinal and connective-tissue support. Often used during post-surgical recovery or in cosmetic protocols.
Frequently asked questions about stacks
- What is a peptide stack?
- A stack is a protocol that uses two or more peptides at the same time, on the assumption that the components target complementary mechanisms. The Wolverine stack pairs BPC-157 (a gastric-pentadecapeptide healing factor) with TB-500 (a thymosin-beta-4 fragment) on the rationale that one supports the gut-vascular axis while the other supports actin remodeling. Whether a given pairing actually outperforms either component on its own is an empirical question, and the published evidence base for most stacks is limited.
- Why do these stacks have nicknames like KLOW and GLOW?
- The nicknames are mnemonics built from the first letter of each component. KLOW combines kisspeptin, the BPC-157/TB-500 healing pair, and GHK-Cu — though specific recipes vary. GLOW is a skin-focused stack typically built around GHK-Cu and other dermal peptides. The naming comes from research-peptide forums, not from clinical trials, and the exact component list often differs by source.
- Are stacks more effective than single peptides?
- There is no general answer. For some pairings — for example, the well-studied combination of a growth-hormone-releasing-hormone analogue (CJC-1295) with a ghrelin-receptor agonist (ipamorelin) — there is a clear pharmacological rationale for combining mechanisms. For most other stacks, the evidence is anecdotal or extrapolated from single-agent studies. Combining peptides also multiplies the variables that can affect tolerability.
- How is reconstitution math handled when peptides are stacked?
- Each peptide is reconstituted in its own vial at its own concentration. Stacks are not blended into a single vial unless a compounding pharmacy has prepared a specific formulation. The calculator treats each component independently — pull up the per-peptide page for each one and the math is the same as for a single peptide.
- Do the stack pages give protocols?
- No. The stack pages document what each named cocktail is, what its components are, the published rationale for the combination where one exists, and citations. They are not protocols and they are not dose recommendations. As with the rest of the site, the framing is educational and presumes a prescribing or research context.
Single-peptide pages and the calculator
For the individual entries that make up these stacks, see the peptide library. The reconstitution calculator handles the per-peptide math from any vial size, and the guides cover BAC water, syringe units, and the underlying reconstitution math.
PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.